Table 2
|
COVID+ ATA
n=32
|
COVID- ATA
n=19
|
p Value
|
Age (years) |
65 ± 13 |
64 ± 15 |
0.88 |
BMI (kg/m2) |
29
± 8 |
27 ± 7 |
0.37 |
Male |
21 (66%) |
12 (63%) |
0.82 |
White |
15 (47%) |
11 (58%) |
0.45 |
Inpatient Therapies |
Inpatient Therapies |
Inpatient Therapies |
Inpatient Therapies |
Vasopressor Use |
29 (91%) |
9 (47%) |
0.00 |
Vasopressor Days |
9 ± 6 |
2 ± 2 |
0.0001 |
Max NE Eq (µg/kg/min) |
0.45 ± 0.51 |
0.28 ± 0.43 |
0.22 |
Mechanical Ventilation |
30 (94%) |
8 (42%) |
0.0001 |
Days on MV |
18 ± 11 |
4 ± 9 |
0.0001 |
Outcomes |
Outcomes |
Outcomes |
Outcomes |
ICU LOS (Days) |
23 ± 8 |
12 ± 11 |
0.0001 |
Hospital LOS (Days) |
25 ± 6 |
17 ± 9 |
0.0001 |
Death |
16 (50%) |
5 (26%) |
0.10 |